The Chemours Company
CC
$14.12
$0.130.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.39B | 1.50B | 1.54B | 1.35B | 1.41B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.39B | 1.50B | 1.54B | 1.35B | 1.41B |
| Cost of Revenue | 1.12B | 1.22B | 1.23B | 1.06B | 1.16B |
| Gross Profit | 273.00M | 286.00M | 306.00M | 286.00M | 255.00M |
| SG&A Expenses | 199.00M | 109.00M | 152.00M | 143.00M | 133.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.35B | 1.35B | 1.41B | 1.24B | 1.32B |
| Operating Income | 48.00M | 148.00M | 128.00M | 115.00M | 96.00M |
| Income Before Tax | 9.00M | -30.00M | 82.00M | 67.00M | -69.00M |
| Income Tax Expenses | 17.00M | -3.00M | 12.00M | 15.00M | -53.00M |
| Earnings from Continuing Operations | -8.00M | -27.00M | 70.00M | 52.00M | -16.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -2.00M |
| Net Income | -8.00M | -27.00M | 70.00M | 52.00M | -18.00M |
| EBIT | 48.00M | 148.00M | 128.00M | 115.00M | 96.00M |
| EBITDA | 126.00M | 226.00M | 202.00M | 186.00M | 170.00M |
| EPS Basic | -0.05 | -0.18 | 0.47 | 0.35 | -0.12 |
| Normalized Basic EPS | -0.03 | 0.40 | 0.29 | 0.29 | 0.12 |
| EPS Diluted | -0.06 | -0.18 | 0.46 | 0.34 | -0.13 |
| Normalized Diluted EPS | -0.03 | 0.40 | 0.29 | 0.28 | 0.12 |
| Average Basic Shares Outstanding | 149.83M | 149.70M | 149.41M | 149.04M | 148.86M |
| Average Diluted Shares Outstanding | 149.83M | 149.70M | 150.12M | 150.05M | 148.86M |
| Dividend Per Share | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Payout Ratio | -450.00% | -140.74% | 52.86% | 71.15% | -205.56% |
